Olazarán-Medrano Z, Treviño-González JJ, Salas-Alanís JC, Lemus-Arias JA

Language: Spanish
References: 21
Page: 83-86
PDF size: 109.13 Kb.

ABSTRACT

Extramammary Paget´s disease (EMPD) is a less common cutaneous type of cancer. It presents as erythematous plaques most frequently located in the genital region, perianal skin, and other cutaneous sites rich in apocrine glands, but it also may originate from keratinocytic stem cells. Recently, imiquimod has been used for the management of primary or relapsing extramammary Paget´s disease. Complete healing, without recurrence, of extramammary Paget´s disease in patients whom were treated topically with 5 % imiquimod cream was observed. We report a 78 year-old patient with scrotal and perianal extramammary Paget´s disease treated with imiquimod cream in both lesions and subsequently with surgical excision in scrotum for the management of relapsing disease.

REFERENCES

1. Paget J. On disease of mammary areola preceding cancer of the mammary gland. St. Bartholomew Hosp Rep 1874;10:87-89.

2. Crocker HR. Paget´s disease affecting the scrotum and penis. Trans Pathol Soc Lond 1888-1889;40: 187-191.

3. Kageyama N, Izumi AK. Bilateral scrotal extramammary Paget´s disease in a Chinese man. Int J Dermatol 1997;36(9):695-697.

4. Chanda JJ. Extramammary Paget´s disease: prognosis and relationship to internal malignancy. J Am Acad Dermatol 1985;13(6):1009-1014.

5. Niedt G. Paget´s disease. En: Rigel DS, Friedman RJ, editores. Cancer of the skin. China: Elsevier; 2005. p. 303-309.

6. Balducci L, Crawford D, Smith G, Lambuth B, McGehee R, Hardy C. Extramammary Paget´s disease: an annotaded review. Cancer Invest 1988;6(3)293-303.

7. Zollo JD, Zeitouni NC. The Roswell Park Cancer Institute experience with extramammary Paget´s disease. Br J Dermatol 2000;142(1):59-65.

8. Chen YH, Wong TW, Lee JY. Depigmented genital extramammary Paget´s disease: a possible histogenetic link to Toker’s clear cells and clear cell papulosis. J Cutan Pathol 2001;28(2):105-108.

9. Wick M, Swanson P, Barnhill R. Sweat gland tumors. En: Barnhill RL, editor. Textbook of dermatopathology. New York: McGraw-Hill; 1998. p. 646- 647, 652.

10. Helm KF, Goellner JR, Peters MS. Immunohistochemical stains in extramammary Paget´s disease. Am J Dermatopathol 1992;14(5): 402-407.

11. Coldiron BM, Goldsmith BA, Robinson JK. Surgical treatment of extramammary Paget´s disease: a report of six cases and a reexamination of Mohs micrographic surgery compared with conventional surgical excision. Cancer 1991;67(4): 933-938.

12. Koh KBH, Nazarina AR. Paget´s disease of the scrotum: report of a case with underlying carcinoma of the prostate. Br J Dermatol 1995;133 (2):306- 307.

13. Chaudhuri SR, Smoller BR. Extramammary Paget ´s disease: diagnosis and disease pattern. Cutis 1992;50(3):195-196.

14. Allan SJR, McLaren K, Aldridge RD. Paget´s disease of the scrotum: a case exhibiting positive prostate-specific antigen staining and associated prostatic adenocarcinoma. Br J Dermatol 1998;138 (4):689-691.

15. Dahl MV. Imiquimod: an immune response modifier. J Am Acad Dermatol 2000; 43(1 Pt 2):S1-S5.

16. Tomai MA, Imberston LM, Stanczak TL, Tygrett LT, Waldschmidt TJ. The immune response modifiers imiquimod and R-848 are potent activators of B lymphocytes. Cell Immunol 2000;203(1):55-65.

17. Perez MA, LaRossa DD, Tomaszewski JE. Paget´s disease primarily involving the scrotum. Cancer 1989;63(5):970-975.

18. Sauder DN. Immunomodulatory and pharmacologic properties of imiquimod. J Am Acad Dermatol 2000;43(1 Pt 2):S6-S11.

19. Kagy MK, Amonette R. The use of imiquimod 5 % cream for the treatment of superficial basal cell carcinomas in a basal cell nevus syndrome patient. Dermatol Surg 2000;26(6):577-579.

20. Cohen PR, Schulze KE, Tschen JA, Hetherington GW, Nelson BR. Treatment of extramammary Paget disease with topical imiquimod cream: case report and literature review. South Med J 2006;99 (4):396-402.

21. Del Rosso JQ. The treatment of viral infections and nonmelanoma skin cancers. Cutis 2007;79(4 Suppl):29-35.